Bekarbon - antispasmodic.
The structure Bekarbona includes belladonna, and sodium bicarbonate.
Belladonna inhibits the production of secretion of the pancreas, stomach, lacrimal, salivary, sweat, bronchial glands, reduces the muscle tone of the gall bladder and ducts, the gastro-intestinal tract, increases intraocular pressure.
Sodium hydrogen reacts with the hydrochloric acid in the stomach and neutralizes it helps to remove sodium and chlorine, improves expectoration.
Form release Bekarbona
Release tablets Bekarbon.
Bekarbon effective in gastritis with high acidity, diarrhea disorders, heartburn, intestinal colic.
Dosing tablets Bekarbon
The drug is taken orally before a meal, one tablet 2-3 p / day. The maximum permissible dose for Bekarbona instructions for adults - 5 tablets at one time or 15 tablets per day.
Bekarbon may cause thirst, dry mouth, urinary retention, dilation of the pupils, intestinal, tachycardia.
If overdose having seizures, agitation, acute urinary retention, blurred vision (accommodation paresis), myocardial ischemia, tachycardia, hyperthermia, impotence, rash,
Bekarbon on instructions do not apply at elevated intraocular pressure (glaucoma), hypertrophy of the prostate gland, caused by violation of the outflow of urine, with hypersensitivity, intestinal atony, atonic constipation, atherosclerosis, diseases of the digestive tract, accompanied by a narrowing of the digestive canal, tachyarrhythmia, decompensated cardiac function, myasthenia During breastfeeding, pregnancy.
During treatment with Bekarbon patient is recommended to observe extreme caution when driving, occupation other activities that require increased attention and visual acuity.
Precautions should be taken Bekarbon patients with hyperthyroidism, ischemia, hypertension, chronic heart failure, polyneuropathy, kidney disease, reflux esophagitis.
Duration of therapy Bekarbonom not recommended for patients with nephrolithiasis, cholelithiasis.
Belladonna increases arrhythmogenic action of cardiac glycosides, MAO inhibitors, clonidine, decreases the effectiveness of anticholinesterase drugs, Mr. anticholinergics.